Chemistry and pharma Why the AI drug revolution has yet to deliver Speed, safety and smarter molecules have yet to translate into better medicines reaching patients. The real breakthrough may come from rethinking what we ask AI to do in the lab, writes Robert Roe Latest Content UK consortium to help accelerate adoption of low carbon medicinal manufacturing ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026 Why the AI drug revolution has yet to deliver New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Protecting bioanalytical data integrity from bench to report Discover how Thermo Scientific™ Watson™ LIMS software safeguards data integrity in bioanalytical studies through traceability, compliance, and automation, reducing regulatory risk and enhancing productivity across the entire bioanalytical process. Future-proofing your lab: key considerations for upgrading or switching chromatography data systems This White Paper guides you in determining whether upgrading your existing system is sufficient or if transitioning to a new CDS is the better, future-ready option. Centralising analytical data from mass spectrometry in drug discovery and development Discover how experts from Zoetis, Bayer, LifeMine Therapeutics, Iterion, Targenomix, and the Pistoia Alliance are solving key data challenges for mass spectrometry applications. Webcasts On Demand: Free Online Panel Discussion | LIMS innovation boosts precision and security Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery More content US NSF director steps down Sign up now for our next roundtable on analytical data challenges in pharma Choosing a flexible digital platform for drug discovery Semiconductor industry escapes latest US tariffs, but end users face uncertainty and increasing prices Lila Sciences to build superintelligence in science Case Study: Facilitating AI/ML in chemistry R&D - data science and high throughput experimentation AI, cloud and IoT driving digital lab transformation as informatics market to hit $8.7bn by 2029 AI in drug discovery: why partnerships could hold the key to better biological data analysis Multimodal drug discovery: how AI, data and collaboration transform pharma Beyond small molecules: A strategic guide to RNA, gene editing & next-gen therapeutics Life sciences data needs protection from cyber criminals: Is AI the answer? Sustainable chemical business: Digital transformation in the chemical supply chain Pagination Previous page ‹ Previous Page 5 Next page Next ›
